Arrowhead Research | ARWR - Current Assets


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Arrowhead Research

Arrowhead Research reported $574.81M in Current Assets for its fiscal quarter ending in March of 2023.


Current Assets Change
Agios Pharmaceuticals AGIO:US USD 791.66M 41.12M
Alnylam Pharmaceuticals ALNY:US USD 2.54B 151.23M
Anika Therapeutics ANIK:US USD 160.33M 9.22M
Arrowhead Research ARWR:US USD 574.81M 189K
Bluebird Bio BLUE:US USD 351.07M 151.58M
Heron Therapeutics HRTX:US USD 178.16M 27.28M
Incyte Corp INCY:US USD 3.97B 121.22M
Intercept Pharmaceuticals ICPT:US USD 490.46M 49.67M
Ionis Pharmaceuticals IONS:US USD 2.54B 339.92M
Ligand Pharmaceuticals LGND:US USD 328.2M 64.59M
Mirati Therapeutics MRTX:US USD 939.35M 169.61M
Moderna Inc MRNA:US USD 12.12B 1.31B
Nektar Therapeutics NKTR:US USD 491.07M 54.9M
Novartis NOVN:VX USD 32.11B 4.8B
Sarepta Therapeutics SRPT:US USD 2.49B 69.48M
Spectrum Pharmaceuticals SPPI:US USD 105.38M 4.37M
TG Therapeutics TGTX:US USD 184.78M 16.51M
Ultragenyx Pharmaceutical RARE:US USD 766.34M 117.56M
Vertex Pharmaceuticals VRTX:US USD 12.97B 269.1M
Xencor XNCR:US USD 629.98M 45.37M